Statistics
Publications
14
Citations
6.9K
H-Index
12
Active since
2013
Jeroen Elassaiss‐Schaap is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in cancer immunotherapy, pharmacology, and pharmacy.
Publications per year
2013–2022
14
14
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Omid Hamid, Caroline Robert, Adil Daud et al. · New England Journal of Medicine · 2013 · 3.4K citations · Full text
Medicine, Immunology, Oncology +17
Malidi Ahamadi, Tomoko Freshwater, Marita Prohn et al. · CPT Pharmacometrics & Systems Pharmacology · 2016 · 150 citations · Full text
1–5 of 14